Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 684.27 | 591.00 | 1732.50 | 0.3411 | -0.1036 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1954.00 | 1732.50 | 1.1278 | 1.1878 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1667.00 | 1732.50 | 0.9622 | 0.9433 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 684.27 | 561.00 | 1732.50 | 0.3238 | -0.1378 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1831.00 | 1732.50 | 1.0569 | 1.0842 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1849.00 | 1732.50 | 1.0672 | 1.0995 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 1137.00 | 1732.50 | 0.6563 | 0.4607 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1701.00 | 1732.50 | 0.9818 | 0.9728 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 684.27 | 1649.00 | 1732.50 | 0.9518 | 0.9276 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 684.27 | 631.00 | 1732.50 | 0.3642 | -0.0587 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1664.00 | 1732.50 | 0.9605 | 0.9407 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3443.00 | 3855.25 | 0.8931 | 0.8475 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3666.00 | 3855.25 | 0.9509 | 0.9306 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1434.95 | 3566.00 | 3855.25 | 0.9250 | 0.8935 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3310.00 | 3855.25 | 0.8586 | 0.7972 |
| BT-20 | Erlotinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3078.00 | 3855.25 | 0.7984 | 0.7079 |
| BT-20 | Lapatinib | 10 | uM | 9 | 2500.00 | 1434.95 | 1424.00 | 3855.25 | 0.3694 | -0.0054 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 3845.00 | 3855.25 | 0.9973 | 0.9963 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1434.95 | 4277.00 | 3855.25 | 1.1094 | 1.1511 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4320.00 | 3855.25 | 1.1205 | 1.1662 |
| BT-20 | Lapatinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3975.00 | 3855.25 | 1.0311 | 1.0434 |
| BT-20 | Linsitinib | 10 | uM | 9 | 2500.00 | 1434.95 | 3403.00 | 3855.25 | 0.8827 | 0.8324 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3083.00 | 3855.25 | 0.7997 | 0.7098 |
| BT-20 | Erlotinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2334.00 | 3855.25 | 0.6054 | 0.4066 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4032.00 | 3855.25 | 1.0458 | 1.0639 |